๐Ÿ‡ฎ๐Ÿ‡ชIreland
16ยฐC Partly Cloudy ยท Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Priya Life Science Clinical trial register
TrackersDrugsComparisonsAPI
Trackers› Clinical trials› Systemic Lupus Erythematosus, SLE
Clinical trial register · China

Systemic Lupus Erythematosus, SLE Trials in China, 2026

Every study on the ClinicalTrials.gov registry that lists a site in China and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage โ€” all 19052 matching records held by the registry are in this view. Synced 22 Sep 2026, 11:10 UTC
19052
Studies in scope
all four open statuses
11786
Recruiting now
open to new participants
2009
Lead sponsors
across recruiting studies
Top sites
Hefei 1 Xuzhou 1 Beijing 1 Tianjin 1
Narrow the registerReset
Recruitment status
Phase
Site location
Hefei1 Xuzhou1 Beijing1 Tianjin1
All 4 locations
Target enrolment
to

Systemic Lupus Erythematosus, SLE trials in China

4 of 19052 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Chinese sites
Start
Recruiting
Exploratory Clinical Study on YTS109 Cell Therapy for Autoimmune Diseases
NCT07236801Systemic Lupus Erythematosus (SLE), Systemic Sclerosis, Sjogren's Syndrome (SS), Inflammatory Myopathy
China Immunotech (Beijing) Biotechnology Co., Ltd.
Phase 1
18
Xuzhou
2025-11-13
Recruiting
A Clinical Study of YTS109 Cells for the Treatment of R/R Autoimmune Diseases
NCT07123519Systemic Lupus Erythematosus (SLE), Lupus Nephritis (LN), Sjogren's Syndrome (SS), Inflammatory Myopathy
China Immunotech (Beijing) Biotechnology Co., Ltd.
Phase 1
18
Tianjin
2025-08-13
Recruiting
A Clinical Study of YTS109 Cell for R/R Autoimmune Diseases
NCT07104721Systemic Lupus Erythematosus (SLE), Lupus Nephritis (LN), Systemic Sclerosis (SSc), Inflammatory Myopathy
China Immunotech (Beijing) Biotechnology Co., Ltd.
Phase 1
18
Hefei
2025-08-04
Recruiting
A Clinical Study of YTS109 Cell in R/R Autoimmune Diseases
NCT06978647Systemic Lupus Erythematosus (SLE), Systemic Sclerosis (SSc), Inflammatory Myopathy, Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis
China Immunotech (Beijing) Biotechnology Co., Ltd.
Phase 1
12
Beijing
2025-05-19
Rows per page Showing 1–4 of 4
1
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a Chinese investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 26 September 2026. https://priyalifescience.com/clinical-trials-china/condition/systemic-lupus-erythematosus-sle

Query this register directly
GET /api/trials?country=cn&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in China and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 19,052 studies in total at the last sync on 22 Sep 2026, 11:10 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 4 of those studies listing the condition Systemic Lupus Erythematosus, SLE that also match the filters currently applied.

How many Systemic Lupus Erythematosus, SLE trials are recruiting in China?

4 of the 4 studies on this page are recruiting new participants as of the 22 Sep 2026, 11:10 UTC sync. A further 0 have not yet opened recruitment, 0 are active but closed to new participants, and 0 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Systemic Lupus Erythematosus, SLE), 4 studies
PhaseStudiesRecruitingShare
Phase 144100%

Most active sponsors

Lead sponsors with the most studies (Systemic Lupus Erythematosus, SLE)
Lead sponsorStudiesRecruiting
China Immunotech (Beijing) Biotechnology Co., Ltd.44
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and India registers.